MDM2 and neoplasm: The BL-0293 bladder PDX model was previously shown to have very low levels of MDM2, which is known to reactivate TP53, and of RB1, a tumor suppressor gene involved in regulating the cell cycle and the tumor’s response to DNA damage caused by cytotoxics like gemcitabine [35].